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Population-level biomonitoring of tin in urine has been conducted by the U.S. National Health and
Nutrition Examination Survey (NHANES) and the National Nutrition and Health Study (ENNS e Etude
nationale nutrition sante) in France. The general population is predominantly exposed to inorganic tin
from the consumption of canned food and beverages. The National Institute for Public Health and the
Environment of the Netherlands (RIVM) has established a tolerable daily intake (TDI) for chronic
exposure to inorganic tin based on a NOAEL of 20 mg/kg bw per day from a 2-year feeding study in rats.
Using a urinary excretion fraction (0.25%) from a controlled human study along with a TDI value of
0.2 mg/kg bw per day, a Biomonitoring Equivalent (BE) was derived for urinary tin (26 mg/g creatinine or
20 mg/L urine). The geometric mean and the 95th percentile tin urine concentrations of the general
population in U.S. (0.705 and 4.5 mg/g creatinine) and France (0.51 and 2.28 mg/g creatinine) are below
the BE associated with the TDI, indicating that the population exposure to inorganic tin is below the
exposure guidance value of 0.2 mg/kg bw per day. Overall, the robustness of pharmacokinetic data
forming the basis of the urinary BE development is medium. The availability of internal dose and kinetic
data in the animal species forming the basis of the assessment could improve the overall conﬁdence in
the present assessment.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Population-level human biomonitoring programs such as the
National Health and Nutrition Examination Survey (NHANES) in the
United States and other national biomonitoring efforts in France,
Canada and Germany are providing valuable data on the prevalence
and concentration of chemicals in the general populations (Angerer
et al., 2011). Measured concentrations of chemicals and their me-
tabolites in a human biological matrix, such as blood or urine, are
potentially useful quantitative markers of exposure. Biomonitoring
data can provide an integrated measure of exposure through all
routes (oral, dermal and inhalation), across all sources, and all
bioavailable forms of the chemical in the environment.
Determining if the exposures measured in biomonitoring pro-
grams are at levels of concern for human health is impeded by the
lack of tools that relate the measurements of exposure and healthces International, 55 Metcalfe
rishnan).
Inc. This is an open access article ueffects. Biomonitoring programs provide exposure data in terms of
concentrations of a chemical in blood or urine, while exposure
guidance values (such the tolerable daily intake level (TDI), refer-
ence dose (RfD)) are typically reported as external dose levels
normalized by body weight (e.g. mg chemical/kg bw per day). In
order to interpret the biomonitoring data quantitatively, forward
dosimetry and reverse dosimetry approaches have been used (eg.,
Sohn et al., 2004; Tan et al., 2007; Georgopoulos et al., 2009;
Environment Canada and Health Canada, 2014). Biomonitoring
Equivalents (BEs) are forward dosimetry tools which have been
developed to aid in the interpretation of biomonitoring data from
population-level studies bymodelling the blood or urine equivalent
of a given exposure guidance value. A BE is deﬁned as the con-
centration or range of concentrations of a chemical or its metabo-
lites in a biological medium (blood, urine or other medium) that is
consistent with an existing health-based exposure guidance values
such as a RfD and TDI (Hays et al., 2007, 2008). BEs have already
been developed for several chemicals, both organic and inorganic,
and used to interpret data from human biomonitoring programs in
the U.S. and Canada in a health-based context (Aylward et al., 2013;nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2014, 2015). Similarly, population-speciﬁc reference values or in-
tervals have been reported for a number of trace elements and
metals based on 24-hr urine from healthy adults (e.g., Sieniawska
et al., 2012). However, BEs which are useful for interpretation of
biomonitoring data in a health-based context have not yet been
developed for a number of metals, including tin.
Tin (Sn; atomic mass¼ 118.71), a silver-white shiny metal, is the
49th most abundant element in earth's crust (Dopp and
Rettenmeier, 2013). The major tin producing countries are China,
Indonesia and Peru (USGS, 2015). The main global use of elemental
tin is for alloys such as brass, bronze and pewter and some welding
materials. Inorganic tin is also extensively used in cans and con-
tainers (including as a protective coating formetal food containers),
construction work, transportation and for electrical uses (USGS,
2015). Inorganic tin is also found in cosmetics, dental care prod-
ucts, coloring agents and food additives (WHO, 2005; Dopp and
Rettenmeier, 2013).
People can be exposed to organic, inorganic and elemental tin
through food, drinking water, consumer products and environ-
mental media (air, soil and dust). However, most of the tin exposure
in the general population is in the form of inorganic tin from the
consumption of canned food and beverages (ATSDR, 2005; WHO,
2005). There are small amounts of tin in fresh meat, cereals and
vegetables but much higher concentrations of tin are found in fruits
and vegetables stored in tin-lined cans (ANSES, 2011). Currently,
most food storage cans contain a lacquer to reduce the migration of
tin into food and this has led to a reduction of dietary intake over
time (JECFA, 2005). Mean dietary intakes for tin range from<1 up to
14 mg/day (<16 up to 233 mg/kg bw per day, assuming 60 kg body
weight) based on tin concentration data from the 1990s from
Australia, France, Japan, the Netherlands, New Zealand, the United
Kingdom and the U.S. (EFSA, 2005; JECFA, 2006). More recently, tin
was measured in the general population diet in France in the Sec-
ond Individual and National Food Consumption Survey (INCA 2)
that took place in 2006e2007 (ANSES, 2011). The mean estimated
tin intake for adults and childrenwere 3.9 and 7.3 mg/kg bw per day,
and the respective 95th percentile for the same age groups were as
17.0 and 31.9 mg/kg bw per day. The main contributors to tin
exposure in both adults and children in France were compotes and
fruits (ANSES, 2011). Drinking water and air are not signiﬁcant
sources of human exposure to inorganic tin (WHO, 2005; ATSDR,
2005).
The current analysis focused on the efforts to interpret bio-
monitoring data for inorganic tin by deriving a BE for existing
exposure guidance value. The objectives of this work are twofold:
(1) to assemble population-level biomonitoring data to identify the
concentrations of urinary tin across the general population; and (2)
to derive a urinary BE for inorganic tin, in view of interpreting the
urinary biomonitoring data for inorganic tin in the general
population.
2. Methods
2.1. Biomonitoring data
A search was conducted for tin concentrations in urine and
blood in national or population-based biomonitoring programs
such as those in the U.S., Canada and Europe. Tin concentrations in
urine were measured as part of the National Health and Nutrition
Examination Survey (NHANES) in the U.S. (http://www.cdc.gov/
nchs/nhanes.htm) and the French National Nutrition and Health
Study (ENNSe Etude nationale nutrition sante; http://www.invs.
sante.fr/publications/2011/exposition_polluants_enns/plaquette_
eng_exposition_polluants_enns.pdf). In a small scale study,Sieniawska et al. (2012) reported tin levels in 24-hr urine samples
of 111 healthy, British subjects. Nomeasurement of tin in blood was
found in the above data sources.
Urinary tin has been suggested as a possible biomarker of long-
term exposures to inorganic tin (ATSDR, 2005). The published data
in animals and humans indicate that inorganic tin absorbed
through gastrointestinal tract is excreted primarily in urine (WHO,
2004; Gad, 2005; RIVM, 2009). The geometric mean and the upper
bound (95th) percentile value of urinary inorganic tin concentra-
tions from biomonitoring studies can be compared with the BE
(developed as described below) to understand the current levels of
population exposure relative to the existing health-based exposure
guidance values (St-Amand et al., 2014).
2.2. Derivation of biomonitoring equivalent (BE)
The process of deriving a BE requires the analysis of relevant
information regarding (i) toxicity and exposure guidance values, as
well as (ii) pharmacokinetic data and models for the chemical
under consideration.
2.2.1. Toxicity and exposure guidance value
Inorganic tin is generally considered to exhibit low order of
toxicity, mainly due to its low absorption, low tissue accumulation
and rapid fecal excretion without absorption from gastrointestinal
(GI) tract (Milne, 1984; WHO, 2004; JECFA, 2011; Dopp and
Rettenmeier, 2013; Ostrokovitch, 2015). In both humans and ani-
mals, GI tissue irritation is the main effect associated with the
ingestion of tin (JECFA, 2011). In humans, nausea, abdominal
cramps, vomiting and diarrhoea have been reported in individuals
who consumed canned beverages and food contaminated with tin
at 150 mg per kg of canned beverages and 250 mg per kg of canned
food (WHO, 2004). In contrast, no adverse effects were reported in
some volunteers who consumed canned foods with tin content
ranging from 250 to 700 mg/kg (WHO, 2004). Evidence from ani-
mal studies suggest that elemental and inorganic tin can interfere
with copper, iron, zinc and calcium status, presumably due to
impaired absorption (The Nordic Expert Group, 2002; WHO, 2005).
The chronic systemic effects for oral exposure to inorganic tin
have been evaluated by ATSDR (2005), WHO (2005) and RIVM
(1993, 2009). RIVM (2009) derived a tolerable daily intake (TDI)
of 0.2 mg tin/kg bw per day based on a no observed adverse effect
level (NOAEL) of 20 mg/kg bw per day from a 2-year feeding study
in rats in which a small increase in tin accumulation in bones and a
decrease in feed efﬁciency were observed at 40 mg/kg bw per day.
RIVM (2009) applied an uncertainty factor of 100 (10 each for inter-
and intra-species variation) to derive a TDI (Table 1). Exposure
guidance values for chronic exposure to inorganic tin were not
established by IPCS (2005), ATSDR (2005) and JECFA (2011) due to
insufﬁcient data or limitations in hazard database.
2.2.2. Pharmacokinetic data & models
A review of the pharmacokinetic data indicates that the ab-
sorption of inorganic tin from the GI tract, which appears to be
mediated by passive diffusion, is low in humans and laboratory
animals, including rats, mice, rabbits, cats and dogs (IPCS, 2005).
While most studies have reported less than 5% GI absorption of
inorganic tin, some report absorption as high as 20% (WHO, 2004).
In humans and laboratory animals, more than 90% of an ingested
dose of inorganic tin is recovered in the faeces (Blunden and
Wallace, 2003). The available data in humans suggest that GI ab-
sorption of inorganic tin decreases with increasing intake (ATSDR,
2005). The GI absorption of inorganic tin is inﬂuenced by the
oxidation state where tin(II) has a greater absorption than tin(IV)
(2.8% and 0.6%, respectively) (WHO, 2004). Inorganic tin distributes
Table 1
Exposure guidance value for inorganic tin.
Exposure guidance, institute & year Critical endpoint Point of departure (POD) UF Exposure
guidance value
TDI
RIVM-National Institute for Public
Health & Environment (RIVM, 2009)
Slight increase in tin accumulation in bones
and a decrease in feed intake efﬁciency at 40 mg
Sn/kg bw per day reported in rats exposed to 0, 200,
400 or 800 mg Sn per kg of food (0,10,20 or 40 mg
Sn/kg bw per day) as stannous chloride. (Sinkeldam
et al., 1981 as cited in JECFA, 1982)
NOAEL ¼ 20 mg
Sn/kg bw per day
100
(10  inter species;
10  human variation)
0.2 mg Sn/kg
bw per day
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nodes, tongue and skin. Laboratory animal data suggest that inor-
ganic tin does not readily cross the bloodebrain barrier (IPCS,
2005). In mammals, tin cations do not appear to be rapidly
oxidized or reduced during absorption and systemic transportation
(IPCS, 2005).
Absorbed tin is predominantly eliminated via urine while only a
small fraction is eliminated via bile (WHO, 2004). In humans, the
clearance of absorbed tin can be separated into three phrases. The
ﬁrst 20% of absorbed tin being cleared with a half-life of 4 days the
second 20% with a half-life of 25 days, and ﬁnal 60% with a much
longer half-life of 400 days (The Nordic Expert Group, 2002). In rats,
the biological half-lives in the bone, spleen and liver were 30e40,
50 and 85 days, respectively (Blunden and Wallace, 2003).
A human metabolic study showed that the fraction of tin
excreted via feces and urine is dependent upon the exposure dose
(Johnson and Greger, 1982). The study provided data on the mass
balance of tin given via a basal (control) diet and a test (tin-sup-
plemented) diet in healthy adult subjects (age: 23.9 ± 2.3 years;
height: 179 ± 7 cm; bodyweight 76 ± 5 kg). Four subjects received a
control diet containing 0.11 mg tin daily (bymeans of 28 frozen and
fresh food items) whereas four other subjects received a test diet
containing an additional 49.56 mg tin as stannous chloride (pro-
vided via juice served at lunch and dinner), for a total dose of
49.67 mg. When subjects were fed a test diet containing 49.67 mg
tin daily, a greater proportion was excreted in feces than urine and
less was absorbed compared to the subjects fed control diet. The
average fecal excretion was 55% of the daily intake in the basal
group and 97% in the supplemented group. The average urinary
excretion was 26% of the daily intake in the basal group and 0.25%
in the supplemented group. It is likely that increased dietary intake
results in increased fecal excretion of unabsorbed tin.
IPCS (2005) reported that the International Commission on
Radiation Protection (ICRP) developed compartmental kinetic
models for ingested and inhaled tin. The model for ingested tinwas
based on an empirical model initially proposed by Furchner and
Drake (1976), which assumes an absorption fraction of 0.02 (i.e.,
2%) through the GI tract and a fractional excretion of 0.5 (i.e., 50%)
through unspeciﬁed excretion routes (ICRP,1981, 2001). The human
model for inhaled tin describes that during nose breathing, 2.5% of
the deposited tin in the GI tract is rapidly absorbed whereas during
mouth breathing, 5% is absorbed (ICRP, 1994). Since the ICRP kinetic
model for ingested tin does not describe the ﬂux through speciﬁc
excretion routes (IPCS, 2005) and moreover there is human data on
urinary excretion fraction associated with oral intake of inorganic
tin (Johnson and Greger, 1982), the use of the ICRP model was not
further explored.2.2.3. Derivation of urinary BE
Urinary tin is the biomarker commonlymeasured in population-
based biomonitoring programs. The BE for inorganic tin was
derived for the urinary matrix, since absorbed tin is predominantly
eliminated via kidneys and the required mass balance and kineticdata are available for the oral route (WHO, 2004). In humans, tin
shows a multi-phased elimination pattern (The Nordic Expert
Group, 2002) and the reported half-life in humans supports the
steady state exposure assumption, even if infrequent exposure
occurs through consumption of canned food (the predominant
source of exposure for the general population). As the primary
source of tin exposure is dietary, measurements of urinary tin may
be representative of long-term steady-state dietary exposures.
A mass balance approach was used to derive a urinary BE
associated with chronic exposure guidance values. Under chronic
exposure conditions leading to near steady-state, the amount
excreted in urine each daywill be equal to the amount ingested (i.e.,
exposure guidance value x body weight) multiplied by a factor
representing the urinary excretion fraction (e.g., Krishnan et al.,
2010a,b). In the current analysis, the mass balance approach (as
explained in Hays et al. (2010)) was used in the derivation of steady
state urinary tin concentrations on a volume basis (mg/L) and
creatinine adjusted (mg/g creatinine) basis.
The steady state urinary concentration of tin on a volume basis
associated with a unit dose for a speciﬁc population sub-group was
calculated using the following formula (Hays et al., 2010):
CV ¼
D BW  FUE:
V
(1)
where CV is the average urinary concentration of tin on a volume
basis (mg/L), D corresponds to the unit dose of tin (1 mg/kg bw per
day), BW is the average bodyweight for the speciﬁc sub-group (kg),
FUE is the urinary excretion fraction, i.e., mass fraction of the daily
intake excreted in the urine, and V is the 24-h average urinary
volume (L).
Similarly, the creatinine-adjusted concentration associated with
a unit dose of tin was calculated as follows:
CC ¼
D BW  FUE
CE
(2)
where CC is the creatinine-adjusted 24-h urinary concentration of
tin, and CE is the 24-h creatinine excretion level.
The urinary excretion fraction FUE, speciﬁed in Eqns. (1) and (2),
was obtained from a metabolic study conducted in human volun-
teers (Johnson and Greger, 1982). This study compared fecal
excretion, urinary excretion and retention of inorganic tin by hu-
man subjects fed 0.11 or 49.67 mg daily. In reference to the data
relevant to the BE derivation, the average urinary loss per day was
reported as 122 mg for a total dietary intake of 49.67 mg in the tin-
supplemented diet group, i.e., FUE ¼ 0.0025. However, for the
control (or basal dietary exposure) group, the daily urinary tin loss
was equal to 29 mg out of a daily dietary intake of 0.11 mg, thus
yielding a FUE value of 0.26. In other terms, FUE values of 0.0025 and
0.26 correspond, respectively, to the daily tin doses of 0.65 mg/kg
per day (¼49.67 mg/76 kg) and 0.0015 mg/kg per day (¼0.11 mg/
76 kg). Given that in the RIVM risk assessment (the source of the
exposure guidance value for the current study) the human-
D. Poddalgoda et al. / Regulatory Toxicology and Pharmacology 81 (2016) 430e436 433equivalent dose for the NOAEL in rats (i.e., 20 mg/kg per day) is
2 mg/kg per day (i.e., NOAEL/interspecies UF of 10), and the TDI is
0.2 mg/kg per day, the FUE value of 0.0025 (associated with a daily
dose of 0.65 mg/kg per day) is considered the appropriate FUE for
deriving a BE in the present study.
3. Results & discussion
3.1. Biomonitoring data
Population-level concentrations of urinary tin in the U.S. and
France are summarised in Table 2. The geometric mean and the
95th percentile in the U.S. population (2011e12) were 0.705 and
4.50 mg/g creatinine, respectively (CDC, 2015). Urinary tin concen-
trations measured in U.S. residents as part of NHANES-III (n ¼ 496,
1988e1994) had a geometric mean and 95th percentile of 2.84 and
16.1 mg/g creatinine, respectively (Paschal et al., 1998). There was a
marked decrease in the concentrations of urinary tin over the 20
year period possibly due to the decreased use of unlacquered or
partially lacquered cans for food storage.
Urinary tin concentrations in the French population had a geo-
metric mean and 95th percentile of 0.51 and 2.28 mg/g creatinine.
These are slightly lower than the U.S. population, potentially due to
differences in dietary patterns between the general populations of
U.S. and France.
In the U.S., among the age groups analysed (6e11, 12e19, 20þ),
urinary tin concentrations were highest in children aged 6e11 and
decreased with age. This age trend has been observed with many
other metals, such as lead, cobalt, zinc and barium (Environment
Canada and Health Canada, 2014; CDC, 2015) and could be due to
higher intake per kilogram of body mass. However, in the French
surveyewhich focussed on adults, therewas an increase in urinary
tin concentration with age (18e39, 40e59, 60e74) (Frery et al.,
2010).
In both American and French populations, women had higher
urinary tin concentrations (creatinine corrected) thanmen. Hayashi
et al. (1991) also reported a similar observation in a small scale
biomonitoring study in Japan. Similar trends have been reported for
other metals, such as cobalt (Finley et al., 2013; Tvermoes et al.,
2014), barium (CDC, 2015) and molybdenum (Health Canada,
2013; CDC, 2015). This may be due to the higher absorption efﬁ-
ciency of metals inwomen compared tomen due to various reasons
including iron deﬁciency commonly found in women. The divalent
form of tin (Snþ2) is the most bioavailable form via GI tract and
some divalent metals (e.g., cobalt) share common intestinal uptake
mechanismwith iron and as a result, iron deﬁciencywould increase
the metal uptake (Blunden and Wallace, 2003; Tvermoes et al.,
2014). However, Sieniawska et al. (2012) found the reverse to be
true, without correcting for creatinine, men had higher urinary tin
excretion and cautioned the interpretation of trace ele-
ment:creatinine ratios for men and women.
3.2. Derivation of urinary BE and interpretation of biomonitoring
data
The urinary concentrations of tin associated with a chronic unit
dose of exposure for different age and sex groups, computed as per
Hays et al. (2010) are presented in Table 3. For the derivation of BE
values, the average bodyweight for adults was assumed as 70 kg for
men and 55 kg for women.
The average predicted concentrations of tin in urine associated
with a unit oral dose varied little across age and sex groups because
in general, daily urinary volume and creatinine excretion rates vary
with body weight (Hays et al., 2010). The average of the computed
urinary concentrations associated with a chronic exposure dose of1 mg/kg bw per day tin across all age groups was carried forward in
calculations of the urinary BE at the point of departure (i.e., expo-
sure guidance value) as explained in Table 4.
A urinary BE of 26 mg/g creatinine was derived for inorganic tin.
This BE represents the concentration of inorganic tin in urine that is
consistent with the TDI of 0.2 mg/kg bw per day established by
RIVM (2009). Comparison of population-level urinary tin concen-
trations (geometric mean and 95th percentile) with the urinary BE
are presented in Fig. 1. The geometric mean and the 95th percentile
of urinary tin concentrations for the general population in the U.S.
and France are below the urinary BE, indicating that current
exposure levels in these populations are below the existing expo-
sure guidance value (TDI). A similar observation can be extended to
the monitoring data representative of the healthy British popula-
tion with normal exposure to trace elements. In this regard,
Sieniawska et al. (2012) reported population level reference in-
tervals (2.5th and 97.5th percentiles) for inorganic tin of 4.8 and
77.9 nmol, based on 24 h urine collected in 111 subjects (77 men
and 34 women), whereas the BE (20 mg/L) developed in the present
study translates to a daily excretion of 286.4 nmol (¼[20 mg/
L  1.7 L/day  1000 ng/mg]/[118.71 ng/nmol]).
3.3. Sources of variability, uncertainty and conﬁdence assessment
The urinary BE derived in the present study does not represent
medical diagnostic criteria and cannot be used to evaluate the
likelihood of an adverse health effect of exposure in an individual.
The BE values derived here should only be used for the interpre-
tation of exposure in the general population consistent with the
intended use of the RIVM TDI. Occupational exposures to tin would
need to be interpreted in the context of biological exposure indices
(BEIs) derived from occupation exposure limits (outside the scope
of this analysis). The assumption underlying the BE derivation is
that the existing TDI for inorganic tin is reasonable and protective.
The purpose of this exercise was not to reassess the existing TDI for
inorganic tin and therefore the derived BE will inherently include
any underlying limitations and uncertainties associated with the
TDI. The urinary BE should be updated or replaced if the TDI is
updated or if a new exposure guidance value is established for
inorganic tin. The derived urinary BE for inorganic tin in the present
study is relevant for the interpretation of population exposure
predominantly in the form of inorganic tin by consumption of
canned food and beverages. This BE is not considered to be relevant
to organic tin, which exhibits different toxicity and toxicokinetic
properties.
The sources and impact of variability in biomarker concentra-
tions in interpreting biomonitoring data have been reviewed
(Bartell et al., 2000; Tardif et al., 2002; Hays et al., 2008; Berthet
et al., 2009; Spaan et al., 2010; Aylward et al., 2012, 2014). The
urinary tin concentration distributions reported in NHANES and
ENNS themselves reﬂect, to some extent, the magnitude and vari-
ability in population exposure to tin. Multiple dietary exposure
events combined with the medium range half-life of inorganic tin
(in terms of weeks) is likely to impart greater conﬁdence in the use
of the BE in interpreting the population-level biomonitoring data
for inorganic tin. Interindividual variations in dietary patterns,
exposure sequences, kinetics and dynamics can contribute to var-
iations in urinary levels of tin. For example, Johnson and Greger
(1982) reported that the urinary excretion of tin was affected by
treatment order, i.e., when the subjects were fed control diets ﬁrst
or test diet ﬁrst. The reported average value (standard deviation)
for two balance periods in these groups were 22 (8), 26 (10), 42 (19)
and 26 (14) mg per day. Given that only the group averages were
provided for the test diets in the Johnson and Greger study (Table 2
of the original publication), those values were used in the present
Table 2
Concentration of urinary tin (mg/g creatinine) for available population level biomonitoring studies.
Study/Population (Survey Years) Age years Sex Sample size Geometric mean (95% CI) 95th percentile (95% CI)
NHANES-III/U.S.a (1988e1994) 6e88 M þ F 496 2.84 16.1
NHANES, U.S.b (2011e2012) 6 years up M þ F 2502 0.705 (0.653e0.761) 4.50 (3.76e5.33)
6 years up M 1261 0.584 (0.524e0.651) 4.17 (2.80e5.55)
6 years up F 1241 0.843 (0.772e0.920) 4.81 (3.50e5.59)
6e11 M þ F 398 1.67 (1.46e1.90) 7.91 (6.11e12.1)
12e19 M þ F 390 0.559 (0.475e0.659) 2.80 (2.00e3.74)
20 years up M þ F 1714 0.665 (0.599e0.737) 4.04 (3.00e5.09)
National Nutrition and Health Study/France (2006e2007)c 18e74 M þ F 1991 0.51 (0.49e0.53) 2.28 (2.14e2.57)
18e74 M 756 0.43 (0.40e0.46) 1.94 (1.75e2.13)
18e74 F 1235 0.61 (0.57e0.60) 3.02 (2.62e3.42)
18e39 M þ F 589 0.46 (0.43e0.49) 2.06 (1.84e2.27)
40e59 M þ F 972 0.54 (0.50e0.57) 2.26 (1.86e2.67)
60e74 M þ F 430 0.58 (0.51e0.65) 2.99 (2.37e3.61)
a NHANES-III/U.S. (1988e1994) e Paschal et al. (1998).
b CDC- NHANES (2015).
c National Nutrition and Health Study/France (2006e2007) - Frery et al. (2010).
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ences were observed between balance periods A and B of the test or
control dietary treatment (i.e, the two balance periods A and Bwere
of 6-day duration, and were preceded by a 6-day adjustment period
and succeeded by a 2-day period for fecal sample collection) for any
variable, including the excretion of tin. The interpretation and use
of data on urinary excretion in the present study correspond to the
limitations of the study of Johnson and Greger (1982). Furthermore,
the use of a factor of 10 to account for intraspecies variation in the
RIVM risk assessment accounts for kinetic and dynamic variability,
including interindividual variation in FUE for inorganic tin.
Apart from the exposure guidance value, the exposure and
toxicokinetic properties also contribute to potential uncertainties
and limitations in the derived urinary BE and its use in the inter-
pretation of biomonitoring data. A central element in the BE deri-
vation relates to the mass fraction of the daily tin intake excreted in
the urine (FUE). Even though a few older studies exist (Kehoe et al.,
1940; Calloway and McMullen, 1966; Tipton et al., 1966, 1969) on
the urinary and fecal excretion of inorganic tin in humans, these
studies either used only two subjects who self-administered vari-
able dietary levels of tin or suffered from analytical problems with
the determination of tin in biological samples (Johnson and Greger,
1982). The existing studies taken together indicate that inorganic
tin is poorly absorbed and that the body might excrete the excess
tin via various routes (feces, pancreatic juice, urine or sweat), withTable 3
Derivation of unit urinary tin concentration associated with a unit oral dose (1 mg/kg/d)
Age group Body weight kga
Children, 6e11 32
Adolescents, 11e16 57
Average, children and adolescents (mg/L urine)
(mg/g creatinine)
Men, >16 70
Women, >16 55
Average adults unit concentration
Average adults unit concentration
Average unit tin concentration (CV), all ages
Average unit tin concentration (CC), all ages
a From Hays et al. (2010).urinary loss being the major route for absorbed tin even though the
actual amounts excreted are small (Calloway and Underwood,
1977; Milne, 1984; WHO, 2004). The FUE values of 0.0025 and
0.26 for inorganic tin were associated with dietary intakes of a
relative higher dose of 49.7 mg (i.e., 0.65 mg/kg bw per day) and a
lower dose of 0.11 mg (i.e., 0.0015 mg/kg bw per day), respectively
(Johnson and Greger, 1982). The intake of 0.0015 mg/kg bw per day
in the human study of Johnson and Greger (1982) relates to the tin
forms that are actually found in diets containing fresh and frozen
foods, whereas the 0.65 mg/kg bw per day dose was achieved
through additional intake of stannous chloride given via juices
provided during lunch and dinner. These and other studies in the
literature indicate that the GI absorption of inorganic tin decreases
with increasing dose possibly reﬂecting a tight homeostatic control
of tin absorption (ATSDR, 2005). ATSDR (2005) further put forth an
alternative explanation for the differences in absorption of tin in
the basal and supplemented diets, in terms of greater absorption of
naturally incorporated tin in food compared to tin added as stan-
nous chloride to food. This then underlines the critical importance
of choosing and using the urinary excretion fraction relevant to the
dose range, particularly where there is data suggestive of dose-
dependent absorption and/or excretion. The actual urinary excre-
tion fraction associated with the intake of 0.0015 mg/kg bw per day
to 0.65 mg/kg bw per day (433-fold different in daily dose) de-
creases from 26% to 0.25%, respectively (Johnson and Greger, 1982).of inorganic tin using equations (1) and (2) as well as FUE ¼ 0.25%.
24 h a
urinary volume, L/d
(Creatinine excretion, g/d)
Unit urinary tin level
mg/L urine
(mg/g creatinine)
0.66
(0.5)
0.121
(0.160)
1.65
(1.2)
0.086
(0.119)
0.104
(0.139)
1.7
(1.5)
0.103
(0.117)
1.6
(1.2)
0.086
(0.115)
0.094
(0.116)
0.099
(0.128)
Table 4
Steps in derivation of urinary BE for RIVM (2009).
Animal POD (NOAEL), mg/kg bw per day: 20
Interspecies UF: 10
Human Equivalent POD, mg/kg bw perday: 2
Human equivalent BEPOD, mg/L: (human equivalent POD  CV from Table 2) 0.198 (¼0.099  2)
Human equivalent BEPOD, mg/g creatinine: (human equivalent POD  CC from Table 2) 0.256 (¼0.128  2)
Intraspecies UF-TK: 3.160
Intraspecies UF-TD: 3.160
Urinary BE, mg/L 20
Urinary BE (mg/g creatinine) 26
D. Poddalgoda et al. / Regulatory Toxicology and Pharmacology 81 (2016) 430e436 435Therefore, it is scientiﬁcally sound to use the FUE value of 0.25% for
BE derivation since it is associatedwith a human dose of 0.65mg/kg
bw per day which, in turn, is in between the range of human-
equivalent no-effect level (2 mg/kg bw per day) and TDI (0.2 mg/
kg bw per day) (RIVM, 2009). However, the general population
intake levels estimated by JECFA (2006) and ANSES (2011) were
much lower than the tin exposure levels in the supplemented
group in Johnson and Greger (1982) study; thus the use of FUE of
0.25% would be a conservative approach.
The use of the alternative FUE value of 26% with the human-
equivalent TDI (i.e., 0.2 mg/kg bw per day) or the supplemental
dose-group in humans (0.65 mg/kg bw per day), would result in
inconsistent and unrealistically large urinary tin values. For
example, for a dietary intake of 0.65 mg/kg bw per day (or
49.67 mg/day), the use of FUE ¼ 0.26 would yield urinary tin levels
of 12.9 mg/day whereas the actual human data indicate urinary tin
excretion of 0.12 mg/day, a value 100 times lower (Johnson and
Greger, 1982). These observations underline the importance of us-
ing dose-relevant absorption or excretion factors for deriving
reference biomonitoring values such as BEs. Overall, the robustness
of pharmacokinetic data (i.e., urinary excretion fraction) forming
the basis of urinary BE development for inorganic tin is medium.
The availability of internal dose and kinetic data in the animal
species forming the basis of the assessment could improve the
overall conﬁdence in the assessment.
In conclusion, the present study derived a urinary BE of 26 mg/g
creatinine for inorganic tin, based on the TDI of 0.2 mg/kg bw per
day established by RIVM (2009). The geometric mean and the 95th
percentile values of the population level urinary biomonitoring
data in U.S. (0.705 and 4.5 mg/g creatinine) and France (0.51 and
2.28 mg/g creatinine) are below the BE associated with the TDI,Fig. 1. Comparison of geometric mean and 95th percentile concentrations of urinary
tin (mg/g creatinine) with the Biomonitoring Equivalent (BE); 26 mg/g creatinine for the
TDI (RIVM, 2009).indicating that the population exposure is below the exposure
guidance value of 0.2 mg/kg per day for inorganic tin.
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